通过调节脂质代谢和免疫微环境,RBM17促进肝细胞癌的进展:对治疗向的影响
Zengbin Wang1, Jiayu Liu2, Yiting Lai3
1Department of Immunology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, 350122, China.
Cell death discovery
|July 23, 2025
概括
替代拼接因子RBM17通过增强M2巨细胞透和改变脂质代谢来促进肝细胞癌 (HCC) 的进展. 准RBM17为HCC患者提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 替代拼接 (AS) 在瘤进展中至关重要.
- 在肝细胞癌 (HCC) 中AS因子RBM17的作用尚不清楚.
研究的目的:
- 调查RBM17在HCC进展中的作用.
- 探索RBM17,HCC脂质代谢和免疫微环境之间的关系.
主要方法:
- 没有标签的蛋白质组学.
- 单细胞测序 (scRNA-seq) 是一种
- 流细胞计 (FCM) 是一种流细胞计.
- 这是LC-MS/MS.
- 多参数免疫光 (mIF) 是一种多参数免疫光.
- 染色体免疫沉 (芯片) 的方法
主要成果:
- 在HCC中RBM17过度表达,并与预后不佳有关.
- 通过增强CSAD前体mRNA外因排除,RBM17通过产出塔罗霍尔酸 (T-CA) 促进M2巨细胞的透.
- RBM17通过调节HACD3前体mRNA外跳转来调节脂肪酸代谢和CD8+T细胞透.
- RUNX1激活RBM17的表达,影响下游的CSAD/T-CA和HACD3/FFA信号传输.
结论:
- 过度表达RBM17驱动HCC的进展.
- 向RBM17可以抑制HCC的进展,表明其治疗潜力.
- RBM17是HCC的有希望的治疗点,为免疫细胞透和新陈代谢提供了洞察力.
更多相关视频
08:25Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
Published on: April 25, 2025
302
09:27Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
Published on: April 1, 2021
3.6K
相关概念视频
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
